Abstract
BackgroundAlemtuzumab is an effective disease modifying treatment (DMT) for people with relapsing multiple sclerosis (pwRMS). Its mechanism of action includes profound lymphocyte depletion.ObjectiveTo analyse the pattern of lymphocyte depletion and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurology, Neurosurgery & Psychiatry
Paper Title
Journal
Date
